Showing results (31-40 of 38) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Therapeutic Advances in Medical Oncology|November 29, 2023
The microtubule inhibitor eribulin demonstrates efficacy in platinum-resistant and refractory high-grade serous ovarian cancer patient-derived xenograft modelsGwo Yaw Ho, Cassandra J Vandenberg, Ratana Lim, et al.JCO Precision Oncology|February 17, 2022
Circulating Tumor DNA Analysis and Functional Imaging Provide Complementary Approaches for Comprehensive Disease Monitoring in Metastatic MelanomaStephen Q Wong, Jeanette M Raleigh, Jason Callahan, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 3, 2020
RAF1 rearrangements are common in pancreatic acinar cell carcinomasOwen W J Prall, Violeta Nastevski, Huiling Xu, et al.Nature Medicine|July 13, 2026
An anti-PMEL antibody-drug conjugate with a Gq/11 inhibitor payload in GNAQ/GNA11-mutant melanomas: a phase 1 trialMatteo S Carlino, Ellen Kapiteijn, Sophie Piperno-Neumann, et al.Cancer Research|July 29, 2021
Acquired RAD51C Promoter Methylation Loss Causes PARP Inhibitor Resistance in High-Grade Serous Ovarian CarcinomaKsenija Nesic, Olga Kondrashova, Rachel M Hurley, et al.JAMA Oncology|March 5, 2026
Genomic Therapy Matching in Rare and Refractory CancersFrank P Lin, Subotheni Thavaneswaran, John P Grady, et al.Journal of Experimental & Clinical Cancer Research : CR|May 4, 2023
Targeting homologous recombination deficiency in uterine leiomyosarcomaGenevieve Dall, Cassandra J Vandenberg, Ksenija Nesic, et al.The New England Journal of Medicine|January 20, 2012
RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitorsFei Su, Amaya Viros, Carla Milagre, et al.Pageof 4